Essex Investment Management CO LLC Crispr Therapeutics Ag Transaction History

Essex Investment Management CO LLC

$536 Million
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$43.47 - $67.77 $9,346 - $14,570	-215 Reduced 44.7%	266 $14,000
Q4 2022 Feb 02, 2023	SELL	$39.19 - $65.67 $693,702 - $1.16 Million	-17,701 Reduced 97.35%	481 $20,000
Q3 2022 Nov 14, 2022	BUY	$61.1 - $83.78 $346,314 - $474,865	5,668 Added 45.29%	18,182 $1.19 Million
Q2 2022 Aug 12, 2022	SELL	$43.23 - $73.83 $790,979 - $1.35 Million	-18,297 Reduced 59.38%	12,514 $760,000
Q1 2022 May 09, 2022	SELL	$53.19 - $79.24 $107,284 - $159,827	-2,017 Reduced 6.14%	30,811 $1.93 Million
Q4 2021 Feb 10, 2022	SELL	$70.09 - $111.29 $80,323 - $127,538	-1,146 Reduced 3.37%	32,828 $2.49 Million
Q3 2021 Nov 09, 2021	BUY	$110.2 - $156.64 $15,207 - $21,616	138 Added 0.41%	33,974 $3.8 Million
Q2 2021 Aug 12, 2021	SELL	$100.84 - $161.89 $171,831 - $275,860	-1,704 Reduced 4.79%	33,836 $5.48 Million
Q1 2021 May 12, 2021	BUY	$110.72 - $210.04 $3.93 Million - $7.46 Million	35,540 New	35,540 $4.33 Million
Q4 2020 Feb 12, 2021	SELL	$79.67 - $173.23 $3.34 Million - $7.27 Million	-41,966 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$78.5 - $100.64 $4,710 - $6,038	-60 Reduced 0.14%	41,966 $3.51 Million
Q2 2020 Aug 04, 2020	SELL	$38.5 - $76.05 $359,782 - $710,687	-9,345 Reduced 18.19%	42,026 $3.09 Million
Q1 2020 May 04, 2020	SELL	$33.68 - $62.53 $1.08 Million - $2.01 Million	-32,077 Reduced 38.44%	51,371 $2.18 Million
Q4 2019 Feb 10, 2020	BUY	$36.68 - $73.13 $169,791 - $338,518	4,629 Added 5.87%	83,448 $5.08 Million
Q3 2019 Oct 22, 2019	SELL	$40.99 - $52.56 $277,912 - $356,356	-6,780 Reduced 7.92%	78,819 $3.23 Million
Q2 2019 Aug 15, 2019	BUY	$35.45 - $48.2 $3.03 Million - $4.13 Million	85,599 New	85,599 $4.03 Million
Q3 2018 Oct 16, 2018	SELL	$44.35 - $65.71 $1.82 Million - $2.69 Million	-40,939 Closed	0 $0
Q2 2018 Jul 17, 2018	BUY	$42.62 - $73.59 $816,130 - $1.41 Million	19,149 Added 87.88%	40,939 $2.41 Million
Q1 2018 Apr 26, 2018	SELL	$23.52 - $58.17 $688,900 - $1.7 Million	-29,290 Reduced 57.34%	21,790 $996,000
Q4 2017 Feb 05, 2018	BUY	$16.95 - $23.48 $865,806 - $1.2 Million	51,080	51,080 $1.2 Million

Others Institutions Holding CRSP

# of Institutions

489

Shares Held

57.9M

Call Options Held

1.1M

Put Options Held

1.9M

Capital International Investors Los Angeles, CA

7.93M
Shares

$315 Million
0.07% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

7.5M
Shares

$298 Million
3.35% of portfolio
State Street Corp Boston, MA

2.99M
Shares

$119 Million
0.01% of portfolio
Sumitomo Mitsui Trust Holdings, Inc.

2.97M
Shares

$118 Million
0.1% of portfolio
Nikko Asset Management Americas, Inc.

2.97M
Shares

$118 Million
1.61% of portfolio

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.1B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Essex Investment Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Essex Investment Management CO LLC with notifications on news.

Account